CNXU — Conexeu Sciences Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 2066836 ·
Last close
$2.00
Market Cap
$56.41M
52W High
$18.79
52W Low
$1.93
ADV30
333,396
Next earnings
2027-01-22

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jul 2026 0 — -7,689,014 -7,725,651 7,156,074 1,971,408 1,305,684
Apr 2026 0 — -2,376,724 -2,304,283 8,199,679 6,848,064 1,003,296
Jan 2026 0 — -1,720,927 -1,718,823 7,702,677 6,255,388 876,275
Oct 2025 0 — -1,873,405 -1,876,873 7,688,711 4,808,965 336,018

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-10,530,844
Investing CF
$-107,171
Financing CF
$12,011,002
CapEx
$-76,629
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.54
As of
2026-09-20

Balance + Analyst (yfinance extras)

Retained Earnings
$-16,270,277
Inventory
—
Receivables
$2,426
ST Investments
—
EBIT TTM
$-13,625,630
Pretax Income TTM
$-13,625,630
Interest Exp TTM
$0
Analysts
1

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Oct 2025 0 -3,958,329 -3,923,557 7,688,711 336,018 7,352,693 -1,669,975
Oct 2024 0 -643,042 -471,867 533,940 438,976 94,964 -225,439

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$7,156,074
Forward EPS
$-0.53

Peers — same industry

TickerNameMarket CapLastDaily %
POSC POSITRON CORP $55.84M $1.70 —
MDNC Medinotec Inc. $58.78M $5.00 —
OM Outset Medical, Inc. $59.64M $3.16 —
COCH Envoy Medical, Inc. $53.20M $6.87 —
AURX Nuo Therapeutics, Inc. $52.79M $1.09 —

News headlines (Yahoo Finance, 1h cache)

Conexeu Sciences Appoints Life Sciences Veteran Daniel M. Bradbury as Chairman of the Board of Directors
2026-11-19 13:30 · Yahoo
Conexeu Sciences Announces Early-Stage Development of W.A.F.E.R.™ Sheet and W.A.F.E.R.™ Lattice, Fabricated Formats of Its Investigational CXU™ Platform
2026-11-17 13:30 · Yahoo
Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration
2026-11-10 13:30 · Yahoo
Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors
2026-10-15 20:30 · Yahoo
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
2026-09-01 15:37 · Yahoo
Conexeu Sciences Sets September and October 2026 Conference Schedule
2026-09-01 12:30 · Yahoo
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
2026-08-11 12:30 · Yahoo
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
2026-07-14 12:30 · Yahoo
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
2026-06-25 12:30 · Yahoo
Is Conexeu Sciences (CNXU) Quietly Redefining Its Commercial Ambitions With CXU Platform Moves?
2026-06-19 06:16 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.